UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in BBNX — Beta Bionics, Inc.
CIK 861177
NEW YORK, NY
Position in BBNX
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,378
+$497 QoQ
Shares Held
88
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#118
of 133 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BBNX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,740,663,804 across 61 Medical Devices names. BBNX ranks #56 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
12,835,753 | $1,164,716,222 | |
| 2 | SYK |
Stryker Corp
|
2,689,376 | $846,723,135 | |
| 3 | DXCM |
Dexcom Inc
|
11,261,876 | $758,487,343 | |
| 4 | BSX |
Boston Scientific Corp
|
13,091,481 | $558,744,402 | |
| 5 | EW |
Edwards Lifesciences Corp
|
5,488,643 | $496,502,640 | |
| 6 | GEHC |
GE HealthCare Technologies Inc.
|
2,541,393 | $162,674,562 | |
| 7 | ZBH |
Zimmer Biomet Holdings, Inc.
|
1,457,553 | $125,480,733 | |
| 8 | BIO |
Bio-Rad Laboratories, Inc.
|
418,884 | $122,988,525 |
All Filings in BBNX
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,378 | 88 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $881 | 88 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $3,199 | 105 | Shares | Defined | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||